What each role should evaluate about the single-compounder model
An owner should evaluate Olympia Pharmacy on formulary coverage and landed cost predictability. Because pricing comes through a clinic agreement with Olympia's clinical liaisons — not a public catalog — the owner confirms the all-in per-vial cost during the sales conversation rather than seeing it before ordering. The key questions are whether Olympia's formulary covers the clinic's top-volume SKUs, what the all-in cost is after any shipping and handling, and whether the clinic-agreement rate holds across refill cycles.
An operations lead should evaluate the DrScript workflow: how orders are submitted patient by patient, how rejected or flagged submissions are surfaced, and how quickly Olympia's clinical liaison team responds to issues. Olympia's overnight shipping and discreet packaging reduce patient-facing friction; the per-patient ordering model means the ops lead does not batch the whole day in one cart the way a multi-partner platform would allow. A prescriber should evaluate SIG entry speed and whether Olympia's clinical pharmacist consulting resource — which Olympia lists as a service — is accessible when protocol questions arise.